secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2025-09-18T23:59:59+00:00
Accession:  0001437749-25-029353
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia prices $6M public offering of 4.8M shares and warrants; up to $6M more from warrant exercise
--------------------------------------------------------------------------------

- Public offering of 4,800,000 shares and short-term warrants for 4,800,000 shares at $1.25 per unit.
- Gross proceeds of $6 million upfront; potential additional $6 million if warrants fully exercised on cash basis.
- Short-term warrants exercisable at $1.25 per share, expire two years from issuance.
- Closing expected September 19, 2025; H.C. Wainwright acting as exclusive placement agent.
- Net proceeds to be used for working capital, advancing biotherapeutic candidates and delivery partnership business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774925029353/0001437749-25-029353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774925029353/bcda20250918_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-029353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer